Cas No.: | 412950-08-4 |
Chemical Name: | 2-(2-((2,3-difluorobenzyl)thio)-4-oxoquinolin-1(4H)-yl)-N-(1-(2-methoxyethyl)piperidin-4-yl)-N-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)acetamide |
Synonyms: | SB-659032;SB 659032 |
SMILES: | COCCN1CCC(CC1)N(CC2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C(=O)CN4C5C(=CC=CC=5)C(=O)C=C4SCC6=C(F)C(F)=CC=C6 |
Formula: | C40H38F5N3O3S |
M.Wt: | 735.814 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | A potent, selective and oral lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with IC50 of 0.23 nM, for the treatment of Alzheimer's disease and atherosclerosis.Alzheimer DiseasePhase 2 Clinical |